Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease

Transplant Proc. 1994 Dec;26(6):3637-9.

Authors

A R Mueller¹, K P Platz, W O Bechstein, G Blumhardt, H Lobeck, U Hop, P Neuhaus

Affiliation

¹ Department of Surgery, University Clinic Rudolf Virchow, Free University of Berlin, Germany.

PMID: 7527984

No abstract available

Publication types

Comparative Study

MeSH terms

Cyclosporine / blood
Cyclosporine / therapeutic use
Drug Monitoring
Graft Rejection / epidemiology*
Graft Rejection / immunology
Hepatitis B / complications
Hepatitis C / complications*
Humans
Immunosuppression Therapy / methods
Incidence
Liver Cirrhosis / etiology
Liver Cirrhosis / surgery*
Liver Cirrhosis, Alcoholic / surgery
Liver Cirrhosis, Biliary / surgery
Liver Transplantation / immunology*
Liver Transplantation / mortality
Muromonab-CD3 / therapeutic use
Retrospective Studies
Survival Rate
Tacrolimus / adverse effects
Tacrolimus / blood
Tacrolimus / therapeutic use*
Time Factors

Substances

Muromonab-CD3
Cyclosporine
Tacrolimus